1.Wenxia Changfu Formula inhibits NSCLC metastasis by halting TAMs-induced epithelial-mesenchymal transition via antagonisticallymodulating CCL18.
Qianyu BI ; Mengran WANG ; Li LUO ; Beiying ZHANG ; Siyuan LV ; Zengna WANG ; Xuming JI
Chinese Journal of Natural Medicines (English Ed.) 2025;23(7):838-847
Our previous research demonstrated that the Wenxia Changfu Formula (WCF), as a neoadjuvant therapy, inhibits M2 macrophage infiltration in the tumor microenvironment and prevents lung cancer metastasis. Given tumor-associated macrophages (TAMs) in epithelial-mesenchymal transition (EMT), this study investigated whether WCF impedes lung cancer metastasis by attenuating TAM-induced EMT in non-small cell lung cancer (NSCLC) cells. Utilizing a co-culture model treated with or without WCF, we observed that WCF downregulated cluster of differentiation 163 (CD163) expression in macrophages, reduced CCL18 levels in the conditioned medium, and inhibited the growth, invasion, and EMT of NSCLC cells induced by macrophage co-culture. Manipulation of CCL18 levels and Src overexpression in NSCLC cells revealed that WCF's effects are mediated through CCL18 and Src signaling. In vivo, WCF inhibited recombinant CCL18 (rCCL18)-induced tumor metastasis in nude mice by blocking Src signaling. These findings indicate that WCF inhibits NSCLC metastasis by impeding TAM-induced EMT via antagonistic modulation of CCL18, providing evidence for its potential development and clinical application in NSCLC patients.
Epithelial-Mesenchymal Transition/drug effects*
;
Carcinoma, Non-Small-Cell Lung/metabolism*
;
Humans
;
Animals
;
Lung Neoplasms/metabolism*
;
Chemokines, CC/antagonists & inhibitors*
;
Mice
;
Mice, Nude
;
Drugs, Chinese Herbal/administration & dosage*
;
Cell Line, Tumor
;
Neoplasm Metastasis
;
Tumor-Associated Macrophages/drug effects*
;
Mice, Inbred BALB C
;
Signal Transduction/drug effects*
2.Imiquimod attenuates airway inflammation and decreases the expression of thymus and activation regulated chemokine in allergic asthmatic mice.
Shu-xian JIN ; Kai-sheng YIN ; Tao BIAN ; Pei-li SUN
Chinese Medical Journal 2006;119(5):412-416
Aminoquinolines
;
pharmacology
;
therapeutic use
;
Animals
;
Asthma
;
drug therapy
;
immunology
;
pathology
;
Bronchoalveolar Lavage Fluid
;
cytology
;
Cell Count
;
Chemokine CCL17
;
Chemokine CCL22
;
Chemokines, CC
;
analysis
;
genetics
;
Cytokines
;
biosynthesis
;
Flow Cytometry
;
Interleukin-4
;
antagonists & inhibitors
;
Male
;
Mice
;
Mice, Inbred BALB C
;
RNA, Messenger
;
analysis
;
STAT6 Transcription Factor
;
analysis
;
antagonists & inhibitors
;
genetics
;
Signal Transduction
;
drug effects

Result Analysis
Print
Save
E-mail